EligibleTrials

Maltodextrin: clinical trials recruiting now

8
Recruiting trials
15
Conditions studied
1
US states with sites
6
Countries

FDA drug label

FDA-approved
Yes. Maltodextrin appears in the FDA drug-label database. Marketed as Aspartame/MSG Detox.
Drug class
Non-Standardized Plant Allergenic Extract; Standardized Chemical Allergen (FDA established pharmacologic class)

FDA-approved use

USES: • For the temporary relief of symptoms including: • headache • dizziness • mood changes • vomiting • nausea • abdominal cramps • abdominal pain • fatigue • weakness These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.

FDA label via openFDA

Phase breakdown

Phase 2 3 Not applicable 5

Conditions being studied

ConditionTrials
Allergy1
Colo-rectal Cancer1
Colorectal cancer1
Eczema1
Hepatic Steatosis1
Hypertension1
Intrahepatic Cholangiocarcinoma (Icc)1
Liver Injury1
Lung cancer1
Metabolic Syndrome1
NASH1
Non Alcoholic Steatohepatitis1
Non-Alcoholic Fatty Liver Disease1
Obesity1
Obesity, Women1

Recruiting trials involving Maltodextrin

Common questions

Is Maltodextrin FDA-approved?

Yes, marketed as Aspartame/MSG Detox.

How many recruiting trials involve Maltodextrin?

8 recruiting trials across 15 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.